Post a Comment Print Share on Facebook
Featured MLB Houston Texans NCIS pedania Andy Reid

Ysios participates in a round of 110 million in Mineralys

The US firm develops a therapeutic solution for resistant hypertension, for which there is no effective treatment.

- 13 reads.

Ysios participates in a round of 110 million in Mineralys

The US firm develops a therapeutic solution for resistant hypertension, for which there is no effective treatment.

The venture capital manager Ysios Capital, specialized in the biotechnology sector, has participated in a round of financing of 118 million dollars (110 million euros) from the US firm Mineralys Therapeutics. The company develops

Avatar
Your Name
Post a Comment
Characters Left:
Your comment has been forwarded to the administrator for approval.×
Warning! Will constitute a criminal offense, illegal, threatening, offensive, insulting and swearing, derogatory, defamatory, vulgar, pornographic, indecent, personality rights, damaging or similar nature in the nature of all kinds of financial content, legal, criminal and administrative responsibility for the content of the sender member / members are belong.